Published in Transplantation on December 27, 2004
Hepatocyte Transplantation for Liver Based Metabolic Disorders | NCT01345578
Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol (2010) 1.52
Barriers to the successful treatment of liver disease by hepatocyte transplantation. J Hepatol (2010) 1.41
Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis (2006) 1.17
Cell and tissue engineering for liver disease. Sci Transl Med (2014) 1.08
Cell delivery: from cell transplantation to organ engineering. Cell Transplant (2010) 1.06
Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives. World J Gastroenterol (2008) 1.03
Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical model. PLoS One (2008) 1.01
Hepatocyte cryopreservation: is it time to change the strategy? World J Gastroenterol (2010) 0.98
Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease. Mol Ther (2009) 0.96
Menstrual blood-derived mesenchymal stem cells differentiate into functional hepatocyte-like cells. J Zhejiang Univ Sci B (2013) 0.95
The possible use of stem cells in regenerative medicine: dream or reality? Langenbecks Arch Surg (2009) 0.90
Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation. Sci Rep (2015) 0.88
Stem cells for liver repopulation. Curr Opin Organ Transplant (2009) 0.86
Hepatocyte transplantation for metabolic liver disease: UK experience. J R Soc Med (2005) 0.86
Monitoring of Liver Cell Transplantation in a Preclinical Swine Model Using Magnetic Resonance Imaging. Cell Med (2010) 0.84
Therapeutic liver repopulation for phenylketonuria. J Inherit Metab Dis (2010) 0.84
Clinical applications of hepatocyte transplantation. World J Gastroenterol (2009) 0.83
Treating inborn errors of liver metabolism with stem cells: current clinical development. J Inherit Metab Dis (2014) 0.81
The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients. Curr Protoc Toxicol (2014) 0.81
How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology? World J Gastroenterol (2012) 0.80
Hepatocyte transplantation program: Lessons learned and future strategies. World J Gastroenterol (2016) 0.78
Liver cell transplantation for the treatment of inborn errors of metabolism. J Inherit Metab Dis (2008) 0.78
Hepatocyte transplantation. J Clin Exp Hepatol (2011) 0.77
Therapeutic hepatocyte transplant for inherited metabolic disorders: functional considerations, recent outcomes and future prospects. J Inherit Metab Dis (2013) 0.77
Experimental hepatocyte xenotransplantation--a comprehensive review of the literature. Xenotransplantation (2015) 0.77
Human liver stem/progenitor cells decrease serum bilirubin in hyperbilirubinemic Gunn rat. World J Gastroenterol (2014) 0.76
Restoring Ureagenesis in Hepatocytes by CRISPR/Cas9-mediated Genomic Addition to Arginase-deficient Induced Pluripotent Stem Cells. Mol Ther Nucleic Acids (2016) 0.76
Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues. J Mater Sci Mater Med (2011) 0.76
Successful auto-implantation of hepatic cells in lung tissue: An animal study. J Res Med Sci (2013) 0.75
The use of cellular technologies in treatment of liver pathologies. Acta Naturae (2012) 0.75
Prospects for Induced Phiripotent Stem Cell-Derived Hepatocytes in Cell Therapy. Cell Med (2011) 0.75
Host conditioning and rejection monitoring in hepatocyte transplantation in humans. J Hepatol (2016) 0.75
Biology of the adult hepatic progenitor cell: "ghosts in the machine". Prog Mol Biol Transl Sci (2010) 0.75
Management of Liver Failure: From Transplantation to Cell-Based Therapy. Cell Med (2011) 0.75
Hepatocyte transplantation in children with liver cell failure. Electron Physician (2016) 0.75
Hepatocyte Transplantation in Special Populations: Clinical Use in Children. Methods Mol Biol (2017) 0.75
Hepatocyte Transplantation: Cell Sheet Technology for Liver Cell Transplantation. Curr Transplant Rep (2017) 0.75
Diagnosis and management of autoimmune hepatitis. Hepatology (2010) 5.27
Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening. Hepatology (2008) 2.98
Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology (2012) 2.81
Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival. Liver Transpl (2007) 2.59
Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30
Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis. Hepatology (2014) 2.29
Adult-to-adult living donor liver transplant: UK experience. Eur J Gastroenterol Hepatol (2003) 2.05
Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl (2002) 2.00
Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure. Liver Transpl (2008) 1.97
Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology (2008) 1.95
Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing. Hepatology (2009) 1.90
Antenatal presentation of biliary atresia. J Pediatr (2004) 1.82
Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl (2006) 1.82
Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology (2006) 1.80
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology (2002) 1.77
Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology (2009) 1.77
Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology (2007) 1.76
Long-term survival following Kasai portoenterostomy: is chronic liver disease inevitable? J Pediatr Gastroenterol Nutr (2003) 1.75
Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol (2006) 1.70
Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology (2007) 1.68
Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol Ther (2005) 1.64
C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet (2008) 1.64
A study of job satisfaction and work environment perception among doctors in a tertiary hospital in Delhi. Indian J Med Sci (2009) 1.63
One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation (2004) 1.62
Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up. J Hepatol (2009) 1.61
Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol (2010) 1.60
Neonatal hemochromatosis--medical treatment vs. transplantation: the king's experience. Liver Transpl (2005) 1.60
Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Liver Transpl (2004) 1.58
The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. Gastroenterology (2002) 1.58
Liver transplantation for propionic acidemia in children. Liver Transpl (2011) 1.56
Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol (2004) 1.54
A genetic study of Wilson's disease in the United Kingdom. Brain (2013) 1.53
Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol (2010) 1.52
Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology (2006) 1.51
Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis. Hepatology (2010) 1.51
Study of Prevalence and Response to Needle Stick Injuries among Health Care Workers in a Tertiary Care Hospital in Delhi, India. Indian J Community Med (2010) 1.51
Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure*. Crit Care Med (2013) 1.51
Aetiology and management of extrahepatic portal vein obstruction in children: King's College Hospital experience. J Pediatr Gastroenterol Nutr (2008) 1.48
Primary pancreatic lymphoma: diagnostic and therapeutic dilemma. Pancreas (2006) 1.47
Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl (2005) 1.47
Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure. J Pediatr Gastroenterol Nutr (2007) 1.47
Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl (2004) 1.45
Living-donor liver transplantation with monosegments. Transplantation (2003) 1.45
Liver transplantation in human immunodeficiency virus-infected patients: procoagulant, but is antithrombotic prophylaxis required? Liver Transpl (2012) 1.45
A clinical prediction rule and platelet count predict esophageal varices in children. Gastroenterology (2011) 1.44
Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia. J Hepatol (2005) 1.44
Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children. J Hepatol (2007) 1.44
Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function. J Biol Chem (2006) 1.44
Death of a living liver donor: opening Pandora's box. Liver Transpl (2013) 1.43
Diaphragmatic dysfunction after pediatric orthotopic liver transplantation. Transplantation (2002) 1.43
The biliary atresia splenic malformation syndrome: a 28-year single-center retrospective study. J Pediatr (2006) 1.42
Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis. Cancer Res (2007) 1.42
Live organ-donation for islet transplantation. Lancet (2005) 1.40
Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics. Hepatology (2005) 1.40
Failure of reactivation of hepatitis B after liver transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients. Transplantation (2002) 1.39
Image of the month. Copper-metallothionein autofluorescence. Hepatology (2009) 1.39
Immunohistochemical phenotyping of the inflammatory infiltrate in de novo autoimmune hepatitis after liver transplantation in children. Pediatr Transplant (2012) 1.38
Autoimmune hepatitis. J Hepatol (2010) 1.38
Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy. Blood (2002) 1.34
Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant (2012) 1.31
Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization. PLoS One (2012) 1.31
Current status of hepatocyte transplantation. Transplantation (2012) 1.28
Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg (2008) 1.25
Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology (2002) 1.23
Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis (2006) 1.17
Autoimmune hepatitis: a comprehensive review. J Autoimmun (2012) 1.16
Overcoming the limitations of living donor and split liver transplantation: a proposal for adult recipients (the best of the East in the West). Liver Transpl (2008) 1.15
The role of mitochondria in ischemia/reperfusion injury. Transplantation (2002) 1.15
Wilson's disease in children: 37-year experience and revised King's score for liver transplantation. Liver Transpl (2005) 1.13
Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD. J Pediatr Gastroenterol Nutr (2010) 1.13
Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun (2005) 1.13
Management of neuroendocrine liver metastases. Am J Surg (2004) 1.13
Variable clinical spectrum of the most common inborn error of bile acid metabolism--3beta-hydroxy-Delta 5-C27-steroid dehydrogenase deficiency. J Pediatr Gastroenterol Nutr (2010) 1.12
Liver transplantation for Budd-Chiari syndrome. Transplantation (2002) 1.12
Aetiopathogenesis of autoimmune hepatitis. World J Gastroenterol (2008) 1.11
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology (2010) 1.10